-
Abstract Introduction Thyroid cancer incidence has tripled in the last decades, resulting in a growing population of survivors. In addition to the risks associated with the cancer itself, cardiovascular disease represents a major cause of morbidity and mortality in thyroid cancer survivors. Our study aims to assess the frequency of cardiovascular and metabolic risk factors in thyroid cancer survivors (TCS). Methods A cross-sectional analysis of thyroid cancer patients at Constantine’s University Hospital, Algeria (January 2021 to July 2022), used the WHO STEPS approach to assess risk factors. Cancer data were extracted from medical records. Results A total of 342 patients were included, of whom 88.9% were women. The mean age was 48 years (range 21–85), papillary thyroid cancer accounted for 82% of cases. The mean survival duration was 4 years (6 months to 32 years), and 74.5% of patients responded well to initial treatment. The current smoking rate was 2.6%, 7.5% of patients engaged in vigorous physical activity, and only 7.8% consumed more than 5 fruits or vegetables daily. At the study time, over 80.7% were overweight or obese, and 86% exhibited android obesity. Hypertension (48.8%), diabetes (27.5%), prediabetes (32.5%), dyslipidemia (77.5%), and metabolic syndrome (61.1%) were common. Factors associated with metabolic syndrome included a family history of obesity (OR) of 1.80 (1.08–3.02), age over 40 OR of 2.71 (1.63–4.51), overweight/obesity OR of 5.134 (2.68–9.84), and levothyroxine doses ≥ 125 µg/day OR of 2.480 (1.45–4.23). Conclusion Cardiovascular and metabolic risk factors are prevalent in our population of thyroid cancer survivors.
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
Abstract Introduction: Thyroid cancer prevalence has increased significantly in recent years, including in Algeria, which primarily concerned microcarcinoma making 30 to 50% of new diagnosed cases. Despite its good prognosis, its management remains highly controversial and debated. We aim to describe characteristics of thyroid microcarcinoma in a series from eastern Algeria monitored in the endocrinology department of Constantine University Hospital and to report the difficulties pertaining to its management. Patients and Methods: A descriptive retrospective study including patients followed and monitored in the thyroid cancer register in the endocrinology department of Constantine University Hospital during the period between January 2015 and December 2018. Results: Of 70 cases of thyroid microcarcinomas, mean age was 44 years [17-84 years] and 94% were women. 94% of the cases were papillary micro carcinomas; the two most frequent variants were the classic papillary and the vesicular variant of papillary carcinoma in 80% of cases. The diagnosis was made following a multi-nodular goiter exploration in 60% and thyroid function was normal in 50%. Moltifocality and bilaterality were reported in 27% and 5.71% of cases respectively. The most common surgical procedure was total thyroidectomy (96%), without lymph node dissection (86%). Classification of the initial risk was impossible due to the insufficient data in 28% of cases. 52% of patients received RAI therapy and 81% were in complete remission. Conclusion: Thyroid micro carcinoma has a good prognosis; however, its management faces several issues, mainly the stratification of risk which would be a source of overtreatment.
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
